Researchers develop blood test for stress

Published Date: 08 Mar 2023

Researchers at Indiana University School of Medicine have developed a blood test for stress. This test assesses a person's risk of stress,...

Read Full News

Latest News

Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD

Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD

6 Psychiatry Headlines You Missed in January 2026

6 Psychiatry Headlines You Missed in January 2026

FDA Examines Generative AI in Psychiatry, With Hans Eriksson, MD, PhD Hans Eriksson, MD, PhD

As mental health AI tools rise, the FDA weighs benefits and risks, emphasizing oversight and performance testing. Eriksson discusses AI in psychiatric care.

Utilizing Alcohol Use Disorder Pharmacotherapy in Hepatology, With Hersh Shroff, MD, MPA Hersh Shroff, MD, MPA

Shroff emphasizes the need to address more than just liver health in patients with alcohol-associated liver disease and reviews trends in AUD pharmacotherapy prescriptions.

The Skin–Brain Axis: Emerging Evidence Transforming Dermatologic Care Lisa A. Swanson, MD, Enzo Berardesca, MD, Mohammad Jafferany, MD

Research reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.

FDA Accepts NDA for Priority Review of Centanafadine to Treat Adult, Pediatric ADHD

FDA Accepts NDA for Priority Review of Centanafadine to Treat Adult, Pediatric ADHD

Todays Updates

A Nutritional Experiment: State-by-State Changes in SNAP

Dr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Residency Training May Formalize Digital Competencies

Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

AI Chatbots Vary Widely on Fake Medical References

A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.

Todays Updates

A Nutritional Experiment: State-by-State Changes in SNAP

Dr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.

Trump Officials Consider Ophthalmologist Hemmati for Top Vaccine Post, Reports Say

The Trump administration is considering appointing Houman Hemmati, an ⁠ophthalmologist and a frequent Fox News guest, to lead the FDA's Center ⁠for Biologics Evaluation and...

Residency Training May Formalize Digital Competencies

Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

AI Chatbots Vary Widely on Fake Medical References

A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.

Latest News

Delay Discounting Fails to Predict MDD Relapse, Q&A With Giles Story, PhD

6 Psychiatry Headlines You Missed in January 2026

As mental health AI tools rise, the FDA weighs benefits and risks, emphasizing oversight and performance testing. Eriksson discusses AI in psychiatric care.

Shroff emphasizes the need to address more than just liver health in patients with alcohol-associated liver disease and reviews trends in AUD pharmacotherapy prescriptions.

Research reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.

FDA Accepts NDA for Priority Review of Centanafadine to Treat Adult, Pediatric ADHD

News All Time

Psychiatry in 2025: Year in Review

Psychiatry in 2025: Year in Review

Teva Pharmaceuticals Submits NDA on TEV-‘749 for Schizophrenia to the FDA

Teva Pharmaceuticals Submits NDA on TEV-‘749 for Schizophrenia to the FDA

Adjunctive Lumateperone Significantly Improves MDD Symptoms by Day 43

Adjunctive Lumateperone Significantly Improves MDD Symptoms by Day 43

4 Psychiatry Headlines You Missed in November 2025

4 Psychiatry Headlines You Missed in November 2025

Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention

Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

Adjunctive Perospirone Safe, Well-Tolerated for MDD in Phase 4 Trial

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

FDA Clears BrainsWay’s TMS Device for Adolescents with MDD Aged 15 to 21 Years

Single Dose of MM120 (LSD) Shows Lasting Anxiety Reduction in GAD: Phase 2b Results Chelsie Derman

A phase 2b trial finds a single 100 μg dose of MM120 reduced GAD symptoms with benefits lasting 12 weeks, highlighting the promise of psychedelic therapy.

FDA Releases CRL Detailing Safety Concerns for MDMA-Assisted Therapy in PTSD Chelsie Derman

MDMA’s CRL, now available to the public, cites gaps in safety data, selection bias, and limited durability.

Prenatal Opioid Pain Medications Likely Not Linked to Autism or ADHD Risk Chelsie Derman

A study suggests associations between opioids during pregnancy and neurodevelopmental disorders are mainly due to confounding factors, not causal effects.

Atopic Eczema Linked to Suicidal Ideation in Global Study of 30,000 Adults Chelsie Derman

EADV 2025 findings show patients with atopic eczema face greater risks of depression, anxiety, sleep disorders, and stigmatization.

FDA Initiates Acetaminophen Label Change, Leucovorin Approval for Cerebral Folate Deficiency Abigail Brooks, MA

The Agency initiated an acetaminophen label change to reflect evidence of potential harms in pregnant women and an approval of leucovorin for CFD.

Daily Ammoxetine at 40, 60 mg Outperforms Placebo for MDD in Phase 2 Trial Chelsie Derman

A phase 2 trial demonstrated the effectiveness, safety, and tolerability of ammoxetine (40 and 60 mg) in patients with major depressive disorder.

APhA, Coalition of Autism Scientists Cite Insufficient Data to Support Acetaminophen, Autism Link Abigail Brooks, MA

Both organizations defend the use of Tylenol during pregnancy, citing “rigorous” and “reputable” research suggesting it does not cause autism in children.

5 Psychiatry Headlines You Missed in September 2025 Chelsie Derman

This month in review focuses on innovative therapies in psychiatry, including MM120 for anxiety and ammoxetine for depression, as well as providing safety insights.

Recommended News For You

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.

Study recommends new grading system for invasive squamous cell carcinoma of the lung

Medical debt in collections persists after cancer diagnosis

Do I qualify for a cancer clinical trial?

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

Recommended Articles For You

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication 

Understanding the Importance of Knowing Your MCV Normal Range 

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review 

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

2.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

3.

These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?

4.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

5.

Video: How to treat kidney disease?

1.

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients

2.

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options 

3.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

4.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

5.

Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XVI

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

3.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot